Standout Papers

METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer 2022 2026 2023 2024168
  1. METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer (2022)
    Huarong Chen, Yasi Pan et al. Gastroenterology
  2. Traditional Medicine Pien Tze Huang Suppresses Colorectal Tumorigenesis Through Restoring Gut Microbiota and Metabolites (2023)
    Hongyan Gou, Hao Su et al. Gastroenterology

Immediate Impact

52 standout
Sub-graph 1 of 24

Citing Papers

ALKBH5-mediated m6A modification of IL-11 drives macrophage-to-myofibroblast transition and pathological cardiac fibrosis in mice
2024 Standout
RNA modifications in cellular metabolism: implications for metabolism-targeted therapy and immunotherapy
2024 Standout
1 intermediate paper

Works of Hao Su being referenced

METTL3 Inhibits Antitumor Immunity by Targeting m6A-BHLHE41-CXCL1/CXCR2 Axis to Promote Colorectal Cancer
2022 Standout
RNA N6-Methyladenosine Methyltransferase METTL3 Facilitates Colorectal Cancer by Activating the m6A-GLUT1-mTORC1 Axis and Is a Therapeutic Target
2020

Author Peers

Author Last Decade Papers Cites
Hao Su 989 399 263 585 133 2.0k
Hu Liu 1106 471 187 401 115 2.5k
Qing Xu 1283 399 197 682 99 2.5k
Yong Fang 1266 713 175 362 124 2.4k
Hiroyuki Tsuchiya 1247 459 302 447 142 2.8k
Jiaojiao Yu 1029 357 164 323 87 2.3k
Bin Wu 688 215 319 581 95 2.1k
Xudong Zhu 946 576 194 344 124 2.2k
Qicai Liu 1444 416 283 312 133 2.6k
Jing Cai 1212 382 102 707 99 2.3k
Baocheng Wang 847 644 149 329 101 2.2k

All Works

Loading papers...

Rankless by CCL
2026